secwatch.observer — SEC 8-K summary
======================================

Issuer:     Apimeds Pharmaceuticals US, Inc. (APUS)
CIK:        0001894525
Form:       8-K
Filed at:   2026-04-16T23:59:59+00:00
Accession:  0001213900-26-044657
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Apimeds expects NYSE notice for late 10-K filing; targets April 30
------------------------------------------------------------------

- Filed Form 12b-25 on March 31, 2026 for FY 2025 10-K; will not file within 15-day extension.
- Expects NYSE American non-compliance notice due to failure to timely file 10-K.
- Plans to file 10-K by April 30, 2026; no assurance given.
- Delay driven by ongoing preparation of financial statements and audit completion.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1894525/000121390026044657/0001213900-26-044657-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1894525/000121390026044657/ea0286661-8k_apimeds.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-044657

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer